Catalyst Wire Dossier Catalyst Wire Dossier

Alecensa

alectinib · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

27 regulatory and trial events tracked for Alecensa, covering 2015-12-11 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: ALECENSA — Supplemental Application (Genentech, Inc.)

See pricing